Amidst growing optimism that viral hepatitis may be eliminated with new treatments and concerted public health efforts, US researchers have raised hopes further by identifying a new approach which may soon lead to a vaccine for hepatitis C.
As Australians celebrate universal access to new hepatitis C treatments, let's visit the stories of South Australians who joined others in speaking out on how important the new medicines are to them.
Photo by Tim Brauhn, Creative Commons
The spiralling rates of liver disease in Australia, and the associated costs in lives and money, need to be addressed by adding new hepatitis C medicines to the PBS.
The continued lack of access to new hepatitis C treatments in Australia is "simply unacceptable".
Australia just gave a major innovation a miss.
Hepatitis Australia's webcast New Hepatitis C Treatment: What You Need To Know can now be watched online.
A recent study published in PLOS One has found that successful hepatitis B vaccination may reduce the risk of diabetes by up to 33 per cent.
Researchers at the University of California Irvine (UCI) have developed a simple cost-effective urine test that detects and confirms hepatitis C virus infections.
Curing hepatitis C in people who inject drugs is more cost effective than waiting until advanced liver disease occurs, studies have shown.
The US Food and Drug Administration (FDA) has approved the use for ledipasvir/sofosbuvir (Harvoni) for people with hepatitis C genotypes 4, 5 and 6, as well as people with HIV.